Category Archives: Stem Cell Doctors


A New FMI Report Forecasts the Impact of COVID-19 Pandemic on Stem Cell Therapies Market Growth Post 2020 – The Scarlet

With 1000+ market research reports and 1 billion+ data points, Future Market Insights (FMI) serves each and every requirement of the clients operating in the global healthcare, pharmaceuticals, and medical device industries. FMI deploys digital intelligence solutions to offer compelling insights to report buyers that help them in overcoming market challenges, especially at the time of a crisis. Our dedicated team of professionals performs an extensive survey for gathering accurate information associated with the market.

FMI, in its upcoming business report, elaborates the historical and current scenario of the Stem Cell Therapies in terms of production, consumption, volume, and value. The report scrutinizes the market into various segments, regions and players on the basis of demand pattern and growth prospects.

Crucial information and forecast statistics covered in the Stem Cell Therapies report will arm both existing and emerging market players with necessary insights to craft long-term strategies as well as maintain business continuity during a crisis such as the ongoing COVID-19 pandemic.

COVID-19 Impact Analysis on Stem Cell Therapies

The recent outbreak of the COVID-19 has turned the spotlight on the healthcare industry, and subsequently impacted the Stem Cell Therapies. Severe shortages of critical medical supplies and a rapid rise in number of COVID-19 cases have resulted into a revolution rather than evolution in the healthcare ecosystems. Consequently, the impact is noticeable in the Stem Cell Therapies.

Following governments measures, particularly social distancing norms and stay-at-home orders, doctors are delaying or postponing elective surgeries unless critical to prevent the spread of the virus to individuals with comorbidities or chronic conditions. Additionally, movement restrictions and supply chain disruptions have created a logistical nightmare for market players, leading to severe product shortages in the global marketplace.

The FMIs report includes an interesting chapter on preliminary impact of the COVID-19 on the Stem Cell Therapies. This allows both leading and emerging market players to understand the market scenario during a crisis and aids them in making sound decisions to gain a distinct competitive edge.

Why Choose Future Market Insights

Discounted prices for new customers! Offer expires soon!

Request Report [emailprotected] https://www.futuremarketinsights.com/reports/sample/rep-gb-1087

Stem Cell Therapies market: segmentation

To analyze the Marketing Stem Cell Therapies effectively and efficiently, the information has been segregated into key segments and sub-segments.

On the basis of treatment:

On the basis of application:

Stem Cell Therapies: Competition Analysis

The FMIs study presents a comprehensive analysis of global, regional, and country-level players active in the Stem Cell Therapies. Competitive information detailed in the Stem Cell Therapies report has been based on innovative product launches, distribution channels, local networks, industrial penetration, production methods, and revenue generation of each market player. Furthermore, growth strategies and mergers & acquisitions (M&A) activities associated with the players are enclosed in the Stem Cell Therapies report.

Key players covered in the report include:

Request Methodology of this Report @ https://www.futuremarketinsights.com/askus/rep-gb-1087

Important Questions Answered in the Stem Cell Therapies Report

Key Offerings of the Report

About Us Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.

Contact Us Mr. Abhishek Budholiya 616 Corporate Way, Suite 2-9018, Valley Cottage, NY 10989, United States T: +1-347-918-3531 F: +1-845-579-5705 T (UK): + 44 (0) 20 7692 8790 Sales: [emailprotected] Press Office: [emailprotected] Blog: Market Research Blog Website: https:www.futuremarketinsights.com

Excerpt from:
A New FMI Report Forecasts the Impact of COVID-19 Pandemic on Stem Cell Therapies Market Growth Post 2020 - The Scarlet

Sophie (5) lit up a room and was a little inspiration – New Ross Standard

Sophie Walsh, who left this world on Tuesday (18th) aged five, was a ray of sunshine who brightened up the lives of everyone who was fortunate enough to meet her.

Sophie, like most children her age, was due to start school this week. After a long, courageous battle with cancer, she succumbed to the illness that afflicted her over three years at Crumlin Children's Hospital on Tuesday.

Born a perfectly healthy child on July 3, 2015, into a loving home, her parents Sandra and Thomas were overjoyed to bring her back to her freshly decorated room in Lacken Valley.

Sophie met all her milestones but just before her second birthday, Thomas and Sandra sensed there was something wrong.

'She was going off her food. We went to doctors, hospitals a couple of times, both in Waterford and Wexford. Then back to the GP and CareDoc. They were all putting it down as a viral thing that would run its course but nothing seemed to be getting any better,' Thomas said.

They brought Sophie to CareDoc one Sunday evening and a doctor noticed a lump which was examined at University Hospital Waterford and the next day Sophie, Thomas and Sandra left for Crumlin, the first of many visits.

'Our lives changed overnight,' Sandra said. 'Our consultant sat us down and laid out a treatment plan which was going to be up to two years. The doctors said it was going to be an intensive time.'

Sophie was diagnosed with neuroblastoma, a cancer of the central nervous system.

The prognosis was 50/50 as Sophie had an amplified version of the illness which made it harder to treat. Thankfully Sophie responded very well to treatment and after a few weeks her energy levels started improving.

'She was back to being normal, except without the hair. She completed ten rounds of chemotherapy and had a break over Christmas and had surgery for her tumour, from which she recovered well. She had her own stem cell transplant in March,' Thomas said.

Throughout, Sandra and Thomas were staying in the Ronald McDonald House near Crumlin on and off, their every waking moment by her side as Sophie recovered from the transplant and had 14 rounds of radiotherapy in St Luke's, being administered a general anaesthetic every day.

She recovered from her treatment and had five rounds, once a month of immune-therapy.

'She finished that in January 2019 and then she was finished. There was no evidence of disease.'

Throughout Sophie couldn't enjoy the social interactions other children take for granted.

'She couldn't have a normal childhood as she was susceptible to infections. She could have cousins and friends around (sometimes). When we could, we did. She was in isolation for 100 days after her bone marrow transplant. Sophie made loads of friends at Crumlin. There were families from throughout Ireland we met up there and became good friends with. She was in Tir na ng playschool (when she could). She was looking forward to starting school.'

Throughout the spring of 2019 Sophie was in great health. 'Everything was going good. She loved her dolls. She loved watching Youtube. Watching kids playing with toys. She loved to play. When she was feeling up to it she wanted to play and when she wasn't she watched TV.'

Recalling a really happy child, an old soul in a child's body, her parents said she was ahead of her years in terms of her conversations and speech. 'She was around adults a lot between nurses and doctors. She had a great imagination. She could pick up a book and even if she couldn't understand the words she'd make up a story from the pictures.'

Sandra said: 'She was very witty; very quick off the mark. She was stubborn as well. If she didn't want to do anything you couldn't change her mind; it was set and that was it.

'We often said she was an old person wrapped up in a small person's body.'

Sophie enjoyed a magical trip to Disneyland with her parents, revelling in meeting Mickey Mouse and all the Disney characters she had seen on TV.

'She loved it!' they said.

Having enjoyed great health all spring of last year, something showed up in a routine scan midway during the summer.

'It was very small and they couldn't be 100 per cent. We had to wait and see what happened. She did a biopsy in September which confirmed she had relapsed and, at that stage, we knew she would have a very poor prognosis of five or six per cent. But we didn't give up hope because she had such a good response the first time around so we thought she could do it again. She had a tough road.'

Due to the location of the cancer within the femur and her tender age, the bone broke the day after the biopsy.

Undeterred Sophie went around in her buggy to trick or treat that Hallowe'en, totally embracing the chance to get dressed up.

'She adapted so well to every challenge. She had a nice Christmas.'

Sophie continued getting treatments after Christmas. 'The treatment she was on wasn't working as well as they liked and there was more progression on it. They switched her onto a different treatment again in February. We were running out of options at this stage.'

Sophie's condition was being kept at bay with the chemotherapy. She still had a good quality of life, but less energy.

'We had been told that the chemo would only work for so long and the cancer can find ways around it and gets used to it. We were always hoping for a miracle and that something would come along.'

Sophie enjoyed a great fifth birthday with friends and family in the garden.

A few weeks later, Aoibhinn's Pink Tie charity staff arranged a princess party at the Horse & Hound for her.

'She had wanted to meet Elsa and Anna. She had her cousins and there was face painting. That was her last good day.'

That evening Sophie started complaining of pain and her leg became more and more swollen.

She was admitted to University Hospital Waterford the following week and a CT scan showed quick progression of the tumour.

Sophie was transferred to Crumlin to help her pain management.

She died on Tuesday, August 18.

'It happened so suddenly. She was tired from treatment. There was one of us with her at all times; we took it in turns.'

Both Thomas and Sandra, who have been out of work since the diagnosis to care for Sophie, said: 'Everything changed so quickly and with the diagnosis and the prognosis we didn't want to wait a second. We didn't want to be looking back in five or ten years time that we had missed out. We had three amazing years. It was just the three of us, especially during lockdown it was nice just to have that time, the three of us.'

They praised the nursing staff of the hospitals Sophie as cared in.

Thomas said: 'Throughout, the whole community were amazing; especially neighbours and local businesses. Even just in terms of support. She was treated like a mini celebrity in The Bakehouse and O'Briens. Everywhere she went on the town everybody knew her and was so good to her. She was a little character as well. Every day she'd say something that made you laugh. She wasn't always in good form but she could change so quick. She would never dwell on things and never left her illness define her; she just kinda got on with it and never talked about it.'

Some of the nurses attended Sophie's funeral, as did staff members from McDonald's in Waterford, a favourite destination for Sophie.

'The nurses left off balloons outside for her. They were so good to her. If she wanted a dance party they held a dance party, copying her moves. The Dunbrody ship was lit up gold for Sophie, ahead of cancer awareness month in September. She would have been starting school this week. We had picked a school and she was looking forward to starting big school.'

Sandra and Thomas left the house on Friday morning for their daughter's funeral.

'All of the neighbours were lined up on either side of the road. We had a garda escort down. Fr Tom Orr gave a lovely, personal eulogy. He was excellent to us and even called to Crumlin to see her. Members of the United Striders stood as guards of honour, as did Urban Gym and Tr na Ng staff.'

'You Are My Sunshine' rang out from the speakers at her funeral Mass, where not a dry eye could be found.

Sophie was laid to rest in St Stephen's Cemetery, not far from her home.

The family want to thank everyone involved in sharing their love of Sophie on Friday, from the guards of honour to their neighbours and the wider community.

Sandra and Thomas said the Ronald McDonald House and Aoibhinn's Pink Tie charities were tremendously supportive throughout the three years.

'When a diagnosis comes, it's rushed and people arrive at John's Ward [in Crumlin] with just the clothes on their back. Even to have a toothpaste and brush.'

They recall in hushed tones, five years of happy memories with Sophie. 'Just being so happy; a family - the three of us. She could just light up a room; she had a presence about her. She would make anybody laugh and left a lasting impression on people who were just drawn to her. She could come out with anything. She told it as it was.'

They spoke of a child who inspired them to have a positive outlook on life and cherish each day as it comes, no matter what.

'For a five-year-old she was so happy go lucky. She inspired us. One day in the hospital she was colouring for the nurses and started colouring squiggles. I said why aren't you doing it properly and she said "life is too boring to just stay between the lines". There is a lot you can learn from a five-year-old, about outlook on life and how to deal with adversity. If Sophie spiked a temperature it means a few days in hospital and there was never any complaining.'

Sophie is dearly missed by Thomas and Sandra, her grandfathers Pat and Billy, aunts, uncles, cousins, extended family and friends.

New Ross Standard

Follow this link:
Sophie (5) lit up a room and was a little inspiration - New Ross Standard

Cell Harvesting Market 2018 Analysis Of Production, Future Demand, Sales And Consumption Research Report To 2023 – The Scarlet

The global market for cell harvesting should grow from $885 million in 2018 to reach $1.5 billion by 2023 at a compound annual growth rate (CAGR) of 11.3% for the period of 2018-2023.

Report Scope:

The scope of the report encompasses the major types of cell harvesting that have been used and the cell harvesting technologies that are being developed by industry, government agencies and nonprofits. It analyzes current market status, examines drivers on future markets and presents forecasts of growth over the next five years.

The report provides a summary of the market, including a market snapshot and profiles of key players in the cell harvesting market. It provides an exhaustive segmentation analysis of the market with in-depth information about each segment. The overview section of the report provides a description of market trends and market dynamics, including drivers, restraints and opportunities. it provides information about market developments and future trends that can be useful for organizations, including wholesalers and exporters. It provides market positionings of key players using yardsticks of revenue, product portfolio, and recent activities. It further includes strategies adopted by emerging market players with strategic recommendations for new market entrants. Readers will also find historical and current market sizes and a discussion of the markets future potential. The report will help market players and new entrants make informed decisions about the production and exports of goods and services.

Get Access to sample pages @https://www.trendsmarketresearch.com/report/sample/11685

Report Includes:

41 data tables and 22 additional tables Description of segments and dynamics of the cell harvesting market Analyses of global market trends with data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023 Characterization and quantification of market potential for cell harvesting by type of harvesting, procedure, end user, component/equipment and region A brief study and intact information about the market development, and future trends that can be useful for the organizations involved in Elaboration on the influence of government regulations, current technology, and the economic factors that will shape the future marketplace Key patents analysis and new product developments in cell harvesting market Detailed profiles of major companies of the industry, including Becton, Dickinson and Co., Corning, Inc., Fluidigm Corp., General Electric Co., Perkinelmer, Inc., and Thermo Fisher Scientific, Inc.

Summary

Stem cells are unspecialized cells that have the ability to divide indefinitely and produce specialized cells. The appropriate physiological and experimental conditions provided to the unspecialized cells give rise to certain specialized cells, including nerve cells, heart muscle cells and blood cells. Stem cells can divide and renew themselves over long periods of time. These cells are extensively found in multicellular organisms, wherein mammals, there are two types of stem cells embryonic stem cells and adult stemcells. Embryonic stem cells are derived from a human embryo four or five days old that is in the blastocyst phase of development. Adult stem cells grow after the development of the embryo and are found in tissues such as bone marrow, brain, blood vessels, blood, skin, skeletal muscles and liver. Stemcell culture is the process of harvesting the exosomes and molecules released by the stem cells for the development of therapeutics for chronic diseases such as cancer and diabetes. The process is widely used in biomedical applications such as therapy, diagnosis and biological drug production. The global cell harvesting market is likely to witness a growth rate of REDACTED during the forecast period of 2018-2023.The value of global cell harvesting market was REDACTED in 2017 and is projected to reach REDACTED by 2023. Market growth is attributed to factors such as increasing R&D spending in cell-based research,the introduction of 3D cell culture technology, increasing government funding, and the growing prevalence of chronic diseases such as cancer and diabetes.

The growing incidence and prevalence of cancer is seen as one of the major factors contributing to the growth of the global cell harvesting market. According to the World Health Organization (WHO), cancer is the second-leading cause of mortality globally and was responsible for an estimated 9.6 million deaths in 2018. Therefore, there is an increasing need for effective cancer treatment solutions globally. Cell harvesting is the preferred method used in cancer cell-related studies including cancer cell databases (cancer cell lines), and other analyses and drug discovery in a microenvironment. The rising prevalence of such chronic diseases has led governments to provide R&D funding to research institutes and biotechnology companies to develop advanced therapeutics. Various 3D cell culture technologies have been developed by researchers and biotechnology companies such as Lonza Group and Thermo Fischer Scientific for research applications such as cancer drug discovery. The application of cell culture in cancer research is leading to more predictive models for research, drug discovery and regenerative medicine applications.

Platelet-rich plasma (PRP) therapy, a new biotechnology solution that has a heightened interest among researchers in tissue engineering and cell-based therapies, has various applications in the treatment of tissue healing in tendinopathy, osteoarthritis and muscle injury. It has been conventionally employed in orthopedics, maxillofacial surgery, periodontal therapy and sports medicines. PRP therapy can be used in the treatment of fat grafting, acne scars, and hair regrowth.

Major factors driving market growth include increasing healthcare costs and the high rate of adoption for modern medicines in emerging economies such as China and India. It has been estimated that India will witness a CAGR of REDACTED in the cell harvesting market during the forecast period. The active participation of foreign pharmaceutical companies has tapped the Indian healthcare sector with a series of partnerships and mergers and acquisitions, which in turn is positively impacting the growth of the market in this region. Consistent development and clinical trials for stem cell therapies, plus contribution from the government and private sectors through investments and cohesive reimbursement policies in the development of cancer biomarkers, is further fueling market growth. InSweden, a research team at Lund University has developed a device to collect fluid and harvest stem mesenchymal stem cells (MSCs). The device is developed with 3D-printed bio-inert plastics which, when used by doctors, can result in the safe extraction of fluids (medical waste) from the patients body. The liquid is then passed through a gauze filter for purifying thoroughly and MSCs are separated from the fluid by centrifugation and are grown in culture.

Follow this link:
Cell Harvesting Market 2018 Analysis Of Production, Future Demand, Sales And Consumption Research Report To 2023 - The Scarlet

Rare group of HIV patients don’t need drugs to suppress virus due to way it integrates in their DNA – Brinkwire

A woman diagnosed with HIV almost 30 years ago may have been cured of the virus without taking drugs or having a bone marrow transplant.

Scientists have studied Loreen Willenberg for decades, with the 66-year-old insisting she has never taken medication to keep the virus at bay. Doctors say her body fights the infection naturally.

But now academics claim she can be added to the list of cured HIV patients, next to theBerlin patient Timothy Ray Brown and the London patientAdam Castillejo.

Both Mr Brown, 54, and Mr Castillejo, 40, had cancer and were given a bone marrow transplant from adonor with HIV-resistant genes to wipe out their disease and the AIDS-causing virus in one fell swoop.

Ms Willenberg who was diagnosed in 1992 and is considered an elite controller because she possesses the rare ability to suppress the virus by itself never had the risky treatment.

Researchers at the Ragon Institute of MGH, MIT and Harvard found no traces of HIV in the Californian woman through standard tests.

Advanced technology that analysed 1.5billion of Ms Willenbergs blood cells found tiny quantities of the virus, meaning she isnt HIV-free. But the doctors revealed her immune system had rendered the leftover traces incapable of reproducing.

Dr Sharon Lewin, director of The Peter Doherty Institute for Infection and Immunity in Australia, told the New York Times: She could be added to the list of what I think is a cure, through a very different path.

Another 63 patients not on anti-retroviral drugs were also found to have traces of HIV that were unable to reproduce.

The team, whose work was published in the journal Nature, say the findings provide evidence that these people have achieved a functional cure.

Elite controllers are only believed to account for 0.5 per cent of the 37million people living with HIV across the world.

Researchers found that, because of where these patients have the virus encoded in their DNA, the pathogen is unable to make copies of itself. Thiskeeps the virus below detectable levels, which makes it untransmissible.

Once a person contracts HIV, the virus sets about attacking and destroying immune cells that normally protect the body from infection.

In the last decade, doctors have gained a much improved understanding of how to control HIV. The rate of deaths from the disease has plummeted since the peak of the AIDS epidemic in the early 1980s.

It is treatable and doctors recommend taking a combination or cocktail of drugs known as antiretroviral therapy, or ART.

Within six months of taking the medication once a day, a persons viral load will be virtually undetectable, but the body wont be completely rid of it.

This is because the virus hides in the body by integrating its genetic material into DNA and forming whats known as a latent reservoir.

But ART which can cause nausea, diarrhoea, headaches and fatigue isnt able to destroy these reservoirs but if an HIV patient ceases taking the cocktail, the virus can start making copies of itself again.

Elite controllers have latent reservoirs, but they dont need to take drugs to stop the virus from spreading throughout the body.

They naturally maintain what other people need ART to do, co-author Dr Mathias Lichterfeld, an infectious disease physician at Ragon, told HealthDay.

For the study, the team looked at blood samples from 64 elite controllers and 41 HIV patients taking ART.

Results showed that, in elite controllers, HIV genetic material was found in so-called gene deserts of the DNA. These are where there is little gene activity so the virus is unable to make copies of itself and instead remain in a blocked and locked state.

Lead author Dr Xu Yu, an associate professor of medicine at Harvard Medical School, said: This positioning of viral genomes in elite controllers is highly atypical.

In the vast majority of people living with HIV-1, HIV is located in the active human genes where viruses can be readily produced.

Dr Yu calls this a functional cure, which occurs when a virus is still in the body but can be controlled without medication.

The researchers believe this is because, in the early days of infection, the immune systems of elite controllers killed the virus after it integrated into DNA regions with a great deal of gene activity.

The team says the findings could lead to a cure, either by creating drugs that replicate the phenomenon of elite controllers or that eliminate HIV thats integrated in parts of the DNA that have substantial gene activity.

Elite controllers carry a mutation of CCR5, which prevents it from expressing, which essentially blocks the gene altogether. Experts say the genetic quirk has descended from northern Europeans.

The study comes after a Brazilian man in his mid-30s with HIV went into long-term remission after treatment with drugs and vitamin B3.

Doctors last month revealed the case of the Sao Paolo patient, who is understood to be the first HIV patient in the world to go into remission following pharmaceutical treatment.

And scientists last year revealed that a third HIV-positive patient in Germany may be free of the virus after undergoing the risky bone-marrow transplant.

But neither the Sao Paolo patient orthe Dsseldorf patient had been free of the virus for long enough to be considered cured.

For example, cancer patients have to be in remission for five years before they are labelled as cured.

Unfortunately, the Berlin and London patients cases do not change the reality much for the millions of people living with HIV.

The treatment is unlikely to have potential on a wider scale because both Mr Castillejo and Mr Ray Brown were given stem cells to treat cancer, not HIV.

Stem cell and bone marrow transplants are life-threatening operations with huge risks. Dangers lie in the patient suffering a fatal reaction if substitute immune cells dont take.

Mr Ray Brown, who is from Seattle but was treated in Germany, has been HIV-free for 12 years without medication.

But Mr Castillejo, whose mental health had spiralled drastically over the years and even led him to consider ending his life, was only treated in 2016.

See the rest here:
Rare group of HIV patients don't need drugs to suppress virus due to way it integrates in their DNA - Brinkwire

FDA Clears Jointechlabs’ MiniTC for Point-of-Care Fat Tissue Processing and its Broad Range of Applications – PRNewswire

SAN FRANCISCO, Aug. 26, 2020 /PRNewswire/ --Jointechlabs a leader in point-of-care regenerative medicine therapies today announced that the U.S. Food and Drug Administration (FDA) cleared the company's MiniTCfor point-of-care fat tissue processing designed to obtain microfat (or fat grafts), for multiple indications. Jointechlabs plans to focus on a range of therapeutic areas including medical aesthetics, plastic surgery, orthobiologics and wound healing.

"The FDA clearance of MiniTC represents an important step forward in the regenerative medicine market," said Nathan Katz, Jointechlabs' CEO. "The company's comprehensive and proprietary technology provides a variety of tissue reconstruction and regeneration options, enabling healthcare practitioners in medical centers, hospitals and clinics to provide safe, reliable and cost-effective cell enriched fat grafts at the point-of-care."

MiniTC is a disposable, closed loop medical device that can be used in the clinic setting, with no change in infrastructure, eliminating the need for manual processing of fat tissue in the lab. Also, the device is less costly,cumbersome and labor intensive compared to what currently exists. MiniTC's performance has been validated in vitro and in vivo, including an observational orthopedic study in Israel and the UAE, involving 47 patients with 92% reporting functional improvement and no complications. Additionally, it was validated in clinical studies with lymphoedema patients as well as in the areas of facial aesthetics, hair regrowth and wound care.

"Jointechlabs' MiniTC device is easy to use and effective," said Joseph Purita, M.D., orthopedic surgeon and director of the Institute of Regenerative Medicine in Boca Raton, Florida."It is encouraging to see the continuing development of new technology for regenerative medicine that is compliant with FDA guidelines."

Microfat IsolationMiniTC allows for processing of adipose (fat) tissue without exposure to the external environment. The final product of the processing is a fine washed fractured fat tissue known as fat graft or microfat. When implanted by injection, the essential effect can be attributed to the preservation of the integrity of fat tissue and the stromal cells within its natural niche. Together it constitutes structural factors that trigger the reconstruction, regeneration and healing of connective tissues.It's a gentle process that uses an individual's own fat tissue tocushion and support areas of injury or damage as the body heals itself.

Pipeline ProductsJointechlabs has an extensive development program. In addition to MiniTC, the company's Mini-Stem a patented, disposable, closed loop medical device is pending approval in Europe (and under investigation in other countries) for isolation of stem cell fraction (SVF) from fat. Mini-Stem will enable doctors to provide safe, reliable, cost-effective non-surgical stem cell treatments at the point-of-care. Mini-Stem will serve as a platform for cell therapies and is well poised to target the developing regenerative medicine market, unlike any of the current devices.Additionally, Jointechlabs is developing proprietary stem cell-scaffold product as a biologic therapy for osteoarthritis, for approval under the FDA's fast-track program. A portion of the pre-clinical study for JTL-T-01 is funded by NIH's small business grant (SBIR grant) in collaboration with Rush University.

Headquartered in San Francisco, Jointechlabs is recognized as an experienced and respected emerging world leader in point-of-care regenerative medicine therapies. With its devices and technology, Jointechlabs enables healthcare practitioners to provide safe, reliable, cost-effective non-surgical regenerative medicine treatments at the point-of-care.For more information, please visit: http://jointechlabs.com/.

Media Contact: Betsy Levy | Phone: (415) 377-3112 | Email: [emailprotected]

SOURCE Jointechlabs

Home

See the original post:
FDA Clears Jointechlabs' MiniTC for Point-of-Care Fat Tissue Processing and its Broad Range of Applications - PRNewswire

ProgenCell – Stem Cell Therapies announces new facilities – PR Web

Our patients will have access to even more services and extraordinary specialists available at the medical tourism complex, in a convenient and strategic location.

SAN DIEGO (PRWEB) August 25, 2020

ProgenCell - Stem Cell Therapies is announcing the opening of its brand new Stem Cell Treatment Center to give international and local patients a more comprehensive medical treatment in a luxury and stress free environment. With this announcement, ProgenCell establishes its leadership in the field of regenerative medicine and medical tourism. ProgenCells New Clinic is part of the one of a kind all-in-house medical tourism complex: NewCity Medical Plaza.

A great deal of planning went into making this stem cell treatment right for the wide range of medical conditions we deal with, said Dr Jorge Gavino, president of ProgenCell Scientific Committee. Our patients will have access to even more services and extraordinary specialists available at the medical tourism complex, in a convenient and strategic location. Im excited to welcome patients at this new facility.

It has been a long journey. Time had given lot of experience since 2008, when the clinic was found, said Elias Bemaras, CEO. Stem cell therapy has evolved, has improved in many ways, getting better results, learning from long term treated patients. We understand the need for a new facility, more convenient for patients with equipment renovation, better distribution, and a better location. Although a high investment is required, we believe it is worth it because our patients will receive better service, easier logistics, more time with the doctor, better follow up, and that translates to 360 degrees patient satisfaction.

With this new facility, ProgenCell establishes its commitment to offer the most advanced technology in modern and comfortable facilities and in a fully licensed, government regulated and certified facility, overseen by an independent ethics and scientific committee.

About ProgenCell - Stem Cell Therapies ProgenCell - Stem Cell Therapies is a leading stem cell treatmentcenter that offers individualized stem cell therapies for patients with chronic-degenerative diseases with more than 10 years of experience. ProgenCell also provides assistance with lodging, traveling and logistics to provide a comprehensive and safe medical tourism experience. ProgenCell is now part of the Health System of NewCity Medical Plaza, a modern and innovative Medical Tourism Center in Tijuana, Mexico. NewCity Medical Plaza is a 30-story tower, with doctors offices, hospital, medical lab, imaging center, commercial plaza, gastronomic center and a 140-room five star hotel.

To learn more about ProgenCell new facilities or scheduling inquiries contact ProgenCell directly at 1 888 443 6235 or email info@progencell.com

Share article on social media or email:

Continue reading here:
ProgenCell - Stem Cell Therapies announces new facilities - PR Web

Religion and The Trump-Pence Ticket – The Tablet Catholic Newspaper

Pope Francis greets Vice President Mike Pence during a meeting at the Vatican in January. (Photo: CNS/Vatican Media)

WINDSOR TERRACE The majority of Americans dont view President Donald Trump as being a religious man, according to a Pew Research poll, but while the president isnt often photographed attending church services, he has frequently evoked religion in his speeches and his actions.

[Related: Trump-Pence 1st Term Record Leaves Catholic Leaders With Mixed Feelings]

Trump is outspoken in his pro-life views on abortion, and in 2020 became the first sitting president to address the March for Life in Washington D.C. in person, rather than appearing via video or a recorded message.

Trump, who was raised in Queens, is a Presbyterian and was confirmed at the First Presbyterian Church in Jamaica in 1959. His parents, Fred and Mary Anne, joined the Marble Collegiate Church in Manhattan in the 1970s. Pastor Norman Vincent Peale ministered to the Trump family for several years until his death in 1993.

The president enjoys strong support within the evangelical community and mentioned religion at several points in his 2020 State of the Union Address.

At one point during the speech, Trump pointed to Robin Schneider, who was seated in the audience with her young daughter Ellie. Ellie was born premature at just 21 weeks in 2017 but was saved by doctors and through the prayers of her parents, Trump said. Ellie reminds us that every child is a miracle of life, the president said. He added that he would ask Congress to pass a bill to ban late-term abortion of babies.

Yet, when Americans were asked in a Pew poll if Trump is religious, the majority thought he didnt have strong beliefs.

According to the poll, 40 percent of respondents said the president is not at all religious and 23 percent replied that he was not too religious. Taken together, thats 63 percent of Americans who think Trump is not very religious.

Only seven percent told pollsters that the president was very religious. Twenty-eight percent said he was somewhat religious.

When asked what Trumps religion is, 32 percent identified him as a Protestant; 34 percent said they had no idea what religion he practices; and 16 percent said he had no religion at all.

Vice President Pence

Vice President Mike Pence, a former congressman and the former governor of Indiana, was raised Catholic and was an altar server at Sunday Masses in his youth. In later years, Pence attended services at Grace Evangelical Church in Indianapolis.

As a congressman, Pence gained a reputation as a staunch pro-life supporter. He adamantly opposed the expansion of abortion rights and fought against federal funding of embryonic stem cell research. He also pushed for a constitutional amendment against same-sex marriage.

During his time as governor, he signed a religious freedom bill into law that allowed businesses and individuals to cite their religious beliefs and refuse to do business with people whose views they find objectionable.

In January of this year, Pence met with Pope Francis at the Vatican.

Pence has often described himself as a born-again, evangelical Catholic.

In another revealing comment, he once told reporters that he was a Christian, a Conservative, and a Republican in that order.

[Related: Trump-Pence 1st Term Record Leaves Catholic Leaders With Mixed Feelings]

Here is the original post:
Religion and The Trump-Pence Ticket - The Tablet Catholic Newspaper

Archbishops vaccine stance out of tune with community – The Age

Illustration: Andrew DysonCredit:

Singing from the same hymn sheet in times of crisis makes both common and ethical sense, which is why reports of the Archbishops of Sydneys suggestion (Archbishops tell PM of tainted vaccine concerns, 25/8) of a Oxford vaccine boycott seems so wildly out of tune with contemporary Australia. COVID-19 has brought out the best in many communities, seeing greater kindness, empathy and compassion but this latest outburst from the same spiritual test tube that invested $2million against marriage equality and threatened politicians who advocated medical abortion is yet another exception to the Australian rule.

Exceptionalism, entitlement and privilege are at the heart of the problem of church leaders who lead prayers for a vaccine but, not liking the answer, send it back to the kitchen. Most ordinary Christian people are genuinely hopeful and want the best for all Australians. It is nonsense to place the interests of any foetus or prelate above finding a vaccine to defend human life. Fr Peter MacLeod-Miller, Rector of Albury, St Matthews Anglican Church

Use of cell lines helps redeem moral status Catholic Archbishop Anthony Fisher and his ecumenical colleagues in their criticism of the projected use of the AstraZeneca vaccine do not seem to have recognised the fact there are bioethicists, both Catholic and Anglican among them, who believe that the subsequent use of such foetal cell lines, far from aggravating the immorality of the original abortion, at least to some degree, redeems it. This subsequent use is not a justification of the original abortion, and, equally certainly, one should not abort in order to generate the foetal cells. But, once the abortion has taken place, rather than consigning the foetus to the hospital waste, the derivation of such cell lines from the foetus for vaccination or for other morally acceptable uses may well be considered morally responsible rather than ethically compromised. William Uren, Parkville

Speculation not only unhelpful but dangerous I live with an anti-vaxxer who I love dearly but our difference in views are increasingly fractious. While, for the nation I hope we develop a COVID-19 vaccine, I despair over the challenge in persuading my partner (and subsequently our children) to vaccinate. The article (Doctors say COVID jab must not be mandatory, 23/8) has galvanised my partners resistance to not only taking a COVID-19 vaccine, but all vaccines and presents another hurdle among the uninformed propaganda peddled by anti-vaxxer groups. If it cant be tested properly it should not be administered. Public discussion on these topics are rapidly contorted by anti-vaxxer groups and recited ad nauseum in many households. Information is contorted then weaponised.

Governments should not release a vaccination until it is entirely safe. Dont speculate on the safety aspects of a yet-to-be-developed vaccination. The AMA and Australian government have just added another string to the bow of the anti-vaxxer propaganda machine. Name and address withheld

Archbishops ought to be commended The three Archbishops of Sydney should be commended for their courageous stand in defense of proper ethical standards in medicine. The foetus didnt give consent to being killed and its body parts used for medical research. Just forget about it you say? It happened 50 years ago and you cant be responsible for that? That would be true if we were animals with no conscience. Like many unethical approaches to science and technologies, disadvantages come back to complicate apparent technical advantages. Stefan Kos, Toorak

Outdated moral theology causes great distress Archbishops have spoken out against the Oxford coronavirus vaccine on the basis that it is derived using human embryonic stem cells obtained from aborted foetuses. Non-Christian religions have no such objection. As a former priest and now retired doctor and psychiatrist, I must warn of the anxiety and distress such outdated moral theology causes in the hearts and minds of the faithful. It has happened before. There is no need for religion in making moral judgments. We all have personal conscience, reason and human empathy that tell us what is right and what is wrong. Dr Peter Evans, Malvern

Too busy to reply Treasurer faces his greatest challenge (26/8) is brilliant. At last we know why those of us who are members of the Kooyong branch of Grandmothers for Refugees, advocating for the human rights of refugees and asylum seekers, never receive replies to the letters we send.

The Treasurer is busy phoning journalists. We in the Kooyong electorate do receive regular email updates telling us of his largesse (with our money) and of his appearances in the media. But nothing about the people our leaders consider voiceless.

The closing comment hits the nail on the head: The bottom line is even his colleagues arent quite sure what he stands for. As grandmothers who are elders in our community, we know that knowing what you stand for is every humans greatest challenge. Our hope is that Mr Frydenberg will discover what he stands for, and that he will be assisted in this by listening to those in our community who are deliberately silenced or preferably unheard. Mary Williams, Camberwell

Pressing matters In early April, I wrote to our local member Michael Sukkars office seeking guidance about consular assistance for our daughter who was stranded in Guatemala. We are yet to receive an acknowledgement from his office. I now understand that he and his staff have been awfully busy attending to other pressing matters. Gloria Bower, Mitcham

Same, same Nick OMalley (Chief Scientist Alan Finkel fires back after criticism on gas, 26/8) reports that Chief Scientist Dr Alan Finkel wrote that greenhouse gas emissions caused by burning coal gas to generate electricity were lower than that created by burning coal. I can assure both OMalley and Dr Finkel that an atom of carbon, whether in the form of coal, or in the form of coal gas derived from coal, will end up as carbon dioxide when burned. In other words, based on carbon content, the emissions of both sources are equivalent. Assoc. Prof. Maurie Trewhella, College of Engineering and Science, Victoria University

Show us the numbers Having some of the nations leading climate change scientists at loggerheads with the Chief Scientist is not a good look. The sooner some ballpark figures for energy generation between now and 2050 are put into the public domain for debate the better. This needs to show how the transition from fossil to renewable energy is expected to track. Once we have an initial pathway outlined, the speed, extent and cost of change can be debated and refined. This might show Dr Finkel and the climate scientists are not too far apart in their thinking. It will also hopefully force a response (and action) from an obstructionist government and vacillating opposition. Peter Thomson, Brunswick

Many lives saved As a GP I am grateful that we have had stage four lockdown. It is the fastest way to reduce deaths and get the economy back to health. Aiming for zero transmission as has happened in other states needs emergency powers, given how many people give themselves exceptions to masks etc. It is unlikely we will have a vaccinated population before September next year. Fighting coronavirus is a marathon, not a sprint. Despite mistakes, clear leadership based on medical evidence has saved many lives. Dr Margaret Beavis, Brighton

Adopt Finnish system I suggest to David Zyngier (Letters, 26/8) that the best way for Australia to reduce social segregation in schooling is to join Finland in fully funding non-government schools and not permitting them to charge fees, or New Zealand which almost fully funds those that charge very low fees. The problem in Australia is not the fact of funding but the use of the socially stratifying Howard/Gonski socio-economic status funding model, the one that ignores school fees. Chris Curtis, Hurstbridge

Hewson insightful What an insightful column from former leader of the Liberal Party John Hewson (Cancerous branch stacking demands leadership, 26/8), regarding the practice of branch stacking. While Labor leaders acted decisively, Prime Minister Scott Morrison has once again been shown up as weak; hand washing and buck passing while he kowtows to the religious right of his party. Gillian Unicomb, Sandford

Power imbalance The fact that Indigenous Australians hold the rights to only a fraction of available surface water in the Murray-Darling basin is another example of the structural inequality that exists in this country (Basin agency warns on water, 26/8). This is no different to the powerlessness of Aboriginal communities to stop the destruction of sacred sites. Only when First Nations Australians are treated as equals while decisions are being made about natural resource development will there be true progress towards reconciliation. Colin Smith, Mount Waverley

Neglect long exposed The Prime Ministers attempt to deflect responsibility for the COVID-19-related disasters in Victorian aged care by pointing to other failures or mismanagement in the control of the pandemic, or by suggesting that Australias record of nursing home deaths is better than other countries, is disgraceful. The neglect and brutality in aged care facilities has been exposed numerous times, including via a royal commission, long before the pandemic. Despite these disclosures, nothing has been done. I wonder how the families who lost loved ones feel, as their relatives deaths are reduced to political point scoring. If our leaders cant take responsibility for their failures, surely they can at least show some compassion. Cheryl Day, Beaumaris

Yearning for dignity Apologising for his governments failure in aged care, Morrison said: On those days when our efforts fall short, none are more sorry than I as Prime Minister. The PMs apology might be genuine, heartfelt even, but families of the residents who have died prematurely in aged care homes, often in the most distressing of circumstances, might see the apology as inefficacious. The Morrison governments lamentable failure in aged care has denied those dying the one thing they might have wished for a basic level of dignity. Neil Hudson, East Melbourne

Sukkar loses my vote Whether or not Michael Sukkar survives the allegations against him, I will not be voting Liberal in Deakin as long as he is the partys candidate. I respect that his socially conservative views are different from mine. As a consequence, I reluctantly put aside his decision to renege on a promise to his electorate that he would vote for the same-sex marriage legislation in December 2017 in accordance with the majority view of Australians. But what I am not prepared to go along with is someone who refuses to appreciate that the party he serves is a broad church and what is worse someone who is actively plotting against Victorian Liberal MPs who do hold views more aligned with mine. Its time to go, Mr Sukkar. Ivan Glynn, Vermont

Urgent scrutiny needed There has been much criticism of Daniel Andrews request to extend emergency powers in Victoria. The fact that other states already have these powers has been omitted from much of the discussion. Yet there has been little scrutiny of the national cabinet, which does not include the Opposition Leader and operates in secrecy. In addition, there is a National COVID-19 Commission stacked with fossil fuel executives who are allegedly making plans to revive our economy without developing renewable energy. This commission also operates in secret and is not required to release details of their meetings. Scrutiny of these bodies is urgently needed. Jen Hooper, Box Hill

Return to the 1950s When will Mr Morrison give women a fair go? His home builder grants disproportionately favour men and he provides little or no JobKeeper support for mostly female-dominated industries such as councils, universities and childcare. Now we see the Defence Force getting $1 billion to increase overall personnel numbers. When you consider that women are also picking up much of the home schooling, it seems the COVID-19 response comes straight from the back-to-the-50s playbook. Donna Wyatt, Wyndham Vale

Tough enough for Defence At a time when the costs of COVID-19 are escalating daily, a $1billion boost in defence spending seems ill considered ($1b defence cash splash, 26/8). When the going gets tough, governments can almost be relied upon to increase defence spending. The notion of building our sovereign industrial capacities exposes the hollow nature of a government which is not prepared to deal properly and meaningfully with the complex problems which face all of us at present, especially the young who, as Ross Gittins points out, have been hardest hit by this pandemic. Helen Scheller, Benalla

Lower voting age Every day, we hear of young people with talent, intelligence and enterprise. Yet they are not entitled to vote. Lets face it, we grown ups have made a mess of the planet. In many places, including Argentina and Scotland, people from the age of 16 are optionally entitled to vote. We should do the same. Young people are the ones who are going to have to put up with the mess weve made. Peter Seligman, Brunswick West

Virus compensation Will Victorian Liberal senator Sarah Henderson (Victorians urged to claim lockdown compensation, 26/8) also support compensation claims against the federal government given they failed to prevent the first arrival of the virus? Steve Melzer, Hughesdale

Credit:

Politics Its Time: Both Michael Sukkar and Kevin Andrews should be sacked from Parliament. Don Vincent, North Warrandyte

Michael Sukkar, another minister behaving badly with impunity. Phil Lipshut, Elsternwick

Hey Scomo, dont take us for suckers time to ditch Sukkar. John Lippmann, Canterbury

The PM and AFL umpires have something in common; inconsistency and incompetency, blame anyone but yourself for a wrong decision and then deny any decision or criticism. Bruce Dudon, Woodend

The PM is pointing the finger of blame at the Premier. Three other fingers are pointing back at him and the thumb is a rude remnant from his bushfire debacle. Greg Curtin, Blackburn South

Coronavirus After moaning to a client in the US about being stuck in stage four restrictions, she casually commented: I wish someone would look after us like that. Enough said. Claire Collins, Flemington

Id far prefer to run with the approach of the epidemiologist, Catherine Bennett (25/8) than I would that of the law graduate, James Moutsias. Merv Wilson, Mitcham

Travellers tales are no longer filling up my Facebook feed. Whats exciting now is parcel tracking. Rilke Muir, Kensington

Gas debate Re Chief Scientist Alan Finkel fires back after criticism on gas (26/8). All gas but no hydrogen. Why? Sally Dammery, Malvern East

Like the debate about climate change, the debate about gas as a transition fuel is over. You cannot fix the problems caused through burning fossil fuels by burning more fossil fuels. Helen Moss, Croydon

Finally Lets hope the Qantas workers about to lose their jobs own millions of Qantas shares so they can take advantage of the share price rise. Tony OBrien, South Melbourne

To submit a letter to The Age, email letters@theage.com.au. Please include your home address and telephone number.

Excerpt from:
Archbishops vaccine stance out of tune with community - The Age

‘I had my penis amputated – so I’ve travelled the world shopping for a new one’ – Mirror Online

Richard Stamp is a stark reminder to men across the country why they need to keep on top of their tackle.

He suffered months of pain but, like many men, he put off seeking medical attention and buried his head in the sand, believing everything would be all right in the end.

But that decision cost him dearly as he ended up losing his penis after being diagnosed with cancer in 2018. His relationship also suffered and he lost his girlfriend.

Doctors had to amputate most of the 54-year-olds organ to save his life.

Now Richard, who works in the entertainment industry, has let cameras into his home as he embarks on a year-long quest to discover ways he can rebuild it, from stem cell growth to reconstruction.

In the Channel 5 documentary Shopping For A New Penis, the cameras capture the heartbreaking moment he discusses his struggles with his ex-partner, Angie.

Richard, who has a son and daughter from a previous relationship, says: Angie and I were together for two years before my cancer was discovered.

He admits he was avoiding sex before his diagnosis as it caused him pain.

It built up over time," he said. "Why I wasnt having penetration was because it really hurt, so I started feeling more vulnerable. Then I just didnt want to do that at all.

During a holiday in Cambodia, Richard felt a lump on his penis, but even then he waited two months to go to the doctor.

He was finally diagnosed in Australia, where he was working at the time.

The medic, Dr Cox, told him he was going to have to have his entire penis amputated.

I met this frightening doctor who, very starkly, said: Your c**ks going to come off, explains Richard, who is from Tooting, South London.

He showed me a model of a c**k, like I was some sort of a farm animal.

"It was so cold. All that went through my mind was panic.

Everything was spinning around thats the worst moment of my lifetime.

Richard flew home for a second opinion and soon discovered that his local hospital, St Georges in Tooting, is Europes leading medical institute dealing with penile cancer.

There, his surgeon, Dr Ben Ayres, confirmed amputation was necessary, but he was able to save a tiny portion of his penis.

Richard says: I remember before the operation, thinking, Im going to run away.

"Then the realisation is where am I going to run to? If I dont do this, Im going to die.

Maybe it sounds crazy if youre not a bloke, but living without a penis makes you question who you are.

I was just a normal bloke before all this happened an Arsenal supporter, a father of two who enjoyed a beer with his mates.

"Then one day I was told by a doctor that my penis had to be removed.

"Since then Ive been trying to work out how I survive without a c**k.

"How I live, work, have sex and go to the toilet, how to be a bloke without having a penis.

Im really angry I let it get that far. I feel a complete fool. I could kick myself because I could have saved it.

One of the main questions Richard is often asked is whether he can still have sex, and he wasted no time finding out.

But he admits that being intimate has been a new challenge.

He says: I was grateful I could still orgasm, but then I had to work out how to do that with a partner, how to share my new body with someone.

But some women dont mind.

Richard is now on a mission to return his manhood to its former glory.

He says: Ive been on a journey to see what the world has to offer, plastic ones, prosthetic ones, even ones grown in laboratories.

He concludes: Im going to go for reconstruction. The process is due to start in February.

Richard has met his new surgeon, Prof David Ralph from University College Hospital in London.

The reconstruction requires three 13-hour surgeries.

Doctors will remove flesh from his arm and bottom to form his new penis, an implant will be placed inside and then a pump will be installed in his scrotum to give him an erection at the touch of a button.

He smiles: Its weird. I want it to feel like me, not an object. Im a bit scared, its like something off Doctor Who from the 70s.

Im going through the mental thought process of building myself up to do this. Ever since my first operation, Ive been taking things weeks at a time, thats all I can do.

The documentary is a warts-and-all look at what happens when you dont listen to your body. Richard is now a speaker for the mens cancer charity, Orchid, and he hopes that people will learn from his costly mistake.

He says: Its sort of inbred in men, isnt it, to be tough? Not talk about stuff, just get on with it. Toughen up, be a man.

"Its such a taboo thing to talk about and to experience, and when I found I had penile cancer, I had no idea it even existed.

So the message to every man watching this documentary is if theres something up, get it checked. If youve got a girlfriend, boyfriend, whatever, hopefully youll be able to talk to them.

If youre on your own, then talk to a friend. The main thing is you must talk to someone. Dont stick your head in the sand like I did.

Cancer of the penis affects around 630 men every year in the UK.

If caught early, around 70% of those diagnosed with it will survive.

It mostly affects men in their 60s.

Symptoms include:

Excerpt from:
'I had my penis amputated - so I've travelled the world shopping for a new one' - Mirror Online

Determined 24-year-old fighting rare aggressive cancer – Northumberland Gazette

Ryan Renton with girlfriend Beth Drummond (left). Ryan was diagnosed with CLL which transferred to Richters syndrome

At 19, Ryan Renton was diagnosed with chronic lymphocytic leukemia (CLL) a rare form of blood cancer after being hospitalised with glandular fever.

Following gruelling treatment, the former Berwick High School student went into remission in 2016 but last October Ryan and his family were given the heartbreaking news that the cancer had returned.

Treatment had been going well for the 24-year-old until he started getting headaches in June and doctors found his cancer had progressed to Richter's syndrome an extremely rare complication with CLL which means Ryans cancer is now more aggressive and fast-growing.

Dad Brian, sister Stacy, Ryan and mum Tracy.

Ryan is now half way through the exhausting chemotherapy treatment and may need radiotherapy ahead of a bone marrow transplant later this year.

Ryan, who worked as a builder with dad Brian, said: Some people take bad to chemotherapy and they have stages where they have to take a break, thankfully my body hasnt reacted in that way. Its the tiredness that affects me the most.

Read More

"With CLL, doctors expected that it would come back. Its just something that I have to deal with, you just have to take it on a daily basis really.

Cancer Research UK says between just two and 10 in every 100 people diagnosed with CLL develop the more aggressive Richters syndrome.

Mum Tracy, 52, said: "Were so proud of him. We just have to support him through it. Ryan being so positive helps us.

"Hes going to get a lot worse before he gets better.

"When he goes in for his bone marrow transplant later this year he will be in hospital for six to eight weeks in isolation.

His family are encouraging people to register to become stem cell donors through DKMS or the Anthony Nolan Trust.

"It will save someones life at the end of the day thats why its very important to have all these donors, added Tracy.

Ryans girlfriend, 20-year-old Beth Drummond, set up a Just Giving page in the hope of raising 500 to help give Ryan the best 25th birthday in October.

Within hours theyd topped their target and now more than 4,600 has been donated.

Ryan is never one to complain, life keeps throwing all these curve balls at him, but he takes them like a boss and always has the most positive attitude, said Beth.

"Hes got a super long journey ahead of him and we are all super proud of him for being so amazing through all of this. Nobody deserves to have to go through this at such a young age.

Covid-19 restrictions means Ryan cant go away but he is looking to buy a gaming computer with the funds donated.

Ryan added: Im overwhelmed with the support. I wanted to thank my football club, Tweedmouth Amateur FC, for all of their support and Luke Dickson and Robyn Pick who were due to complete the Gateshead Half Marathon for Berwick Cancer Cars so they ran a course around Berwick instead.

The rest is here:
Determined 24-year-old fighting rare aggressive cancer - Northumberland Gazette